BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 58 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,693 | -15.4% | 26,499 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 26,499 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 26,499 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -97.7% | 26,499 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $261,000 | +1435.3% | 26,499 | 0.0% | 0.01% | – |
| Q3 2021 | $17,000 | -26.1% | 26,499 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $23,000 | – | 26,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 202,950 | $2,009,000 | 0.05% |
| Kingstown Capital | 300,000 | $27,000 | 0.04% |
| RAMIUS ADVISORS LLC | 567,986 | $51,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 88,875 | $880,000 | 0.02% |
| Q Global Advisors, LLC | 300,000 | $27,000 | 0.02% |
| MARSHALL WACE, LLP | 575,000 | $5,693,000 | 0.01% |
| HGC Investment Management Inc. | 2,443,365 | $403,000 | 0.01% |
| Corbin Capital Partners, L.P. | 464,062 | $42,000 | 0.01% |
| LMR Partners LLP | 50,000 | $495,000 | 0.01% |
| Telemetry Investments, L.L.C. | 153,694 | $6,000 | 0.01% |